Further studies have revealed that they efficiently induce neoantigen-specific CD4+ T cells, activate tumor-reactive CD8+ T cells, and promote the polarization of naïve CD4+ T lymphocytes into Th1 or Th17/Th1 cells (30–32, 36). Here, CD4 is linked to neoplasm.